Inventor · disambiguated record
Nicholas Kindon
Also filed as: KINDON NICHOLAS · KINDON NICHOLAS D · KINDON NICHOLAS DAVID
17 granted patents·5 pending applications·283 citations·filing 1995–2012
94Inventor score
Top patents by PatentIndex Score
22 records- 0190US5721219AN-alkyl-2-substituted ATP analogues and administration to inhibit platelet aggregationASTRA PHARMA PROD·Filed 1995·Granted Feb 24, 1998·85 cites·12 claims
- 0287US6812226B2P2X7 receptor antagonists for use in the treatment of inflammatory, immune or cardiovascular diseaseASTRAZENECA AB·Filed 2000·Granted Nov 2, 2004·33 cites·14 claims
- 0384US6518286B1CompoundsASTRAZENECA AB·Filed 2000·Granted Feb 11, 2003·19 cites·12 claims
- 0478US8148373B2CompoundsALCARAZ LILIAN·Filed 2009·Granted Apr 3, 2012·3 cites·20 claims
- 0578US5955447AN-alkyl-2-substituted ATP analogues for treatment of embolic disease conditionsASTRA PHARMA PROD·Filed 1997·Granted Sep 21, 1999·44 cites·7 claims
- 0675US6218376B1Uracil compounds as P2-purinoreceptor 7-transmembrane G-protein coupled receptor antagonistsASTRAZENECA UK LTD·Filed 1998·Granted Apr 17, 2001·20 cites·16 claims
- 0773US6946478B2CompoundsASTRAZENECA AB·Filed 2003·Granted Sep 20, 2005·6 cites·15 claims
- 0870US7410972B2CompoundsASTRAZENECA AB·Filed 2002·Granted Aug 12, 2008·6 cites·16 claims
- 0963US5985849APhosphate compounds and their use as medicamentsASTRA PHARMA PROD·Filed 1998·Granted Nov 16, 1999·20 cites·12 claims
- 1062US7662825B2N-pyrazinyl-phenylsulphonamides and their use in the treatment of chemokine mediated diseasesASTRAZENECA AB·Filed 2003·Granted Feb 16, 2010·1 cites·14 claims
- 1161US6562825B1Piperazine derivatives as modulators of chemokine receptor activityASTRAZENECA UK LTD·Filed 2000·Granted May 13, 2003·1 cites·11 claims
- 1260US6107297A2,4-Dithi(oxo)-pyrimidin-5-yl compounds bearing a tricyclic substituent useful as P2 purinoceptor antagonistsASTRA PHARMA PROD·Filed 1998·Granted Aug 22, 2000·17 cites·12 claims
- 1360US2010144759A1Novel n-(fluoro-pyrazinyl)-phenylsulfonamides as modulators of chemokine receptor ccr4ASTRAZENECA AB·Filed 2009·Application pending·0 cites
- 1459US6162808ACompoundsASTRAZENECA U K LTD·Filed 1998·Granted Dec 19, 2000·19 cites·10 claims
- 1558US2010081670A1N-pyrazinyl-phenylsulphonamides and their use in the treatment of chemokine mediated diseasesBAXTER ANDREW·Filed 2009·Application pending·0 cites
- 1653US8476265B2Compounds-801ALCARAZ LILIAN·Filed 2012·Granted Jul 2, 2013·0 cites·15 claims
- 1752US8629271B2CompoundsALCARAZ LILIAN·Filed 2012·Granted Jan 14, 2014·0 cites·1 claims
- 1852US2008293742A1Novel N-(Fluoro-Pyrazinyl)-Phenylsulfonamides as Modulators of Chemokine Receptor Ccr4CHESHIRE DAVID·Filed 2006·Application pending·0 cites
- 1950US6200981B1Pyrimidin derivativesASTRAZENECA UK LTD·Filed 1998·Granted Mar 13, 2001·9 cites·11 claims
- 2048US8455483B2Compounds—801ALCARAZ LILIAN·Filed 2010·Granted Jun 4, 2013·0 cites·15 claims
- 2146US2007093491A1Novel condensed n-pyrazinyl-sulphonamides and their use in the treament of chemokine mediated diseasesBAXTER ANDREW·Filed 2004·Application pending·0 cites
- 2239US2002086862A1Novel compoundsASTRAZENECA AB·Filed 2001·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Nicholas Kindon files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →